Pharma Inc gets back to life beyond Covid

August 1, 2022

For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.

More To Explore

JSW Infrastructure shares debut at 20% premium over IPO price

JSW Infrastructure has priced the issue in the range of Rs 113-119 per share. The IPO, which is entirely a fresh equity issue of Rs

October 3, 2023

Chart Check: Nearly 50% rally in 3 months! Should investors buy or book profits in this cable maker?

Short to medium-term traders can look to buy the stock for a target of Rs 5650 in the next 1-2 months, they say.

October 3, 2023

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Generated by Feedzy